Ombitasvir
Back to searchMolecule Structure
Scientific Name
Ombitasvir
Description of the Drug
Ombitasvir is a direct acting antiviral agent used in combination with other antiviral agents for the treatment of Hepatitis C Virus (HCV) infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09296
http://www.drugbank.ca/drugs/DB09296
Brand Name(s)
Not Available
Company Owner(s)
Abbvie Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Nonstructural protein 5A | SINGLE PROTEIN | INHIBITOR | CHEMBL3307224 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL8542284 |
| PharmGKB | PA166163409 |
| DrugBank | DB09296 |
| PubChem: Thomson Pharma | 131532517 |
| PubChem | 54767916 |
| Nikkaji | J3.279.162J |
| BindingDB | 50453112 |
| DrugCentral | 4912 |
| Guide to Pharmacology | 11272 |
| rxnorm | OMBITASVIR |
| ChEBI | 85183 |
| ZINC | ZINC000150601177 |
